南京招聘

Key Responsibilities主要岗位职责:
l.Receive/determine net requirements from/with commercial, and balance supply and demand through communicating and agreeing the Supply plan with the commercial side according to the timetable contained within CSA , resolving exceptions where possible or escalating to line management if required
2.Develop capacity plans based on future net requirements and make available for management decision purposes, so as to support GSKNJ business plan and ensure that sufficient supply capability is in place to support growth of existing products and the successful launch of new products.
3.Develop the purchasing plan based on the MPS and manage the inventory level to achieve financial inventory target.
4.Coordinate the transferring process of new product into Operations.Maintain BPCS system and implement new function / model in BPCS system so as to compliant the requirements of GSK / Enterprise process and GMP, assist to upgrade MRPII system with IT and regional support.
5.Develop and maintain the Net Requirement to GSK inter suppliers.Train BPCS system new users, and answer related question.
6.Lead, motivate and facilitate training to develop planners to achieve individual and functional goal.

Specialized Knowledge 专业知识:
1. Bachelor's Degree in Pharmacy, Business Administration, or Operations is preferred, Or equivalent experience.
2.At Least five years working experience in pharmaceutical industry and familiar with pharmaceutical manufacturing process
3.Sound capability in English oral speaking and writing and CET should be 4 or above 4.Strong oral and written communication skills
5.Knowledge on supply chain management, MRPII and ERP will be preferred
6.High degree of flexibility and problem solving skills.
7.Ability to interact with different levels of management within the organization

南京美瑞制药有限公司于1996年由美国远东荷克公司、瑞典法玛西亚?普强?艾勒根公司和南京医药股份有限公司合资成立，注册地址: 南京经济技术开发区新港大道50号，公司注册资本:17345.2212万元人民币。
2011年1月葛兰素史克公司(GSK)收购美瑞制药。
2016年10月凯德思达（北京）医药控股集团有限公司与葛兰素史克公司(GSK)公司完成美瑞制药的股权转让，美瑞制药成为凯德思达（北京）医药控股集团的全资子公司。
    美瑞制药是泌尿系统领域产品研发、生产和销售的专业制药企业，在国内处于先导地位。其中用于治疗良性前列腺增生（BPH）的舍尼通和治疗膀胱过度活动症（OAB）的舍尼亭及舍尼亭缓释片是其领军产品。
    美瑞制药占地面积32000多平米、建筑面积近8000平米、绿化面积占公司面积的60%。
    美瑞制药分别于2000年、2005年、2010年和2013年一次性通过GMP（复）认证。经过近二十年的经营发展，美瑞制药建立了自己独特的运作模式，构建了泌尿系统领域产品从研发、生产、销售的完整体系。拥有了一支专业化的人才队伍，形成了以 TOP 价值观为核心的企业文化。
    美瑞制药的经营宗旨是通过持续的管理创新与技术创新，不断增加新产品，成为中国泌尿领域药品的领导者，并始终以关爱、关心和理解的情怀，致力于不断满足患者的健康需求。
美瑞愿景：改善人类的健康状况，建设行业内***管理的公司，为社会提供卓越的产品和服务，为股东提供出色的收益 。
美瑞价值观（TOP）： 团队协作（Teamwork）
                    开放包容（Open-minded）
                    专业至善（Professional）
    美瑞精神：正德、勤奋、睿思、拓达